Related Experiment Videos
Pulmonary presentations of amyloidosis
M E Howard1, J Ireton, F Daniels
1Department of Respiratory Medicine, Austin Repatriation Medical Centre, Heidelberg, Victoria, Australia. m.howard@pgrad.unimelb.edu.au
Respirology (Carlton, Vic.)
|March 27, 2001
Summary
Amyloidosis affecting the respiratory tract is uncommon. This study found that endobronchial and nodular pulmonary amyloidosis cases had good survival, unlike systemic or interstitial forms.
Area of Science:
- Pulmonology
- Oncology
- Pathology
Background:
- Amyloidosis, a rare condition involving protein buildup, can affect the respiratory system.
- Lower respiratory tract amyloidosis presents in various forms, including interstitial, endobronchial, and nodular.
Observation:
- Eight cases of lower respiratory tract amyloidosis were analyzed.
- These included isolated pulmonary interstitial amyloidosis, recurrent endobronchial amyloidosis with airway obstruction, and localized nodular pulmonary amyloidosis.
- Circulating monoclonal immunoglobulins were detected in five patients, suggesting a potential cause.
Findings:
- Endobronchial and nodular pulmonary amyloidosis cases showed good long-term survival.
- Systemic or interstitial pulmonary amyloidosis cases exhibited progressive disease and poor survival outcomes.
- Laser therapy proved effective for airway obstruction in endobronchial amyloidosis.
Implications:
- Prognosis for respiratory tract amyloidosis varies significantly based on the specific type.
- Identifying circulating monoclonal immunoglobulins may aid in diagnosis and understanding pathogenesis.
- Further research into targeted therapies for different forms of pulmonary amyloidosis is warranted.